Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Type: Journal article
Title: PC-3 cells with enhanced androgen receptor signaling: A model for clonal selection in prostate cancer
Author: Buchanan, G.
Craft, C.
Yang, M.
Cheong, A.
Prescott, J.
Jia, L.
Coetzee, G.
Tilley, W.
Citation: The Prostate, 2004; 60(4):352-366
Publisher: Wiley-Liss
Issue Date: 2004
ISSN: 0270-4137
Statement of
Grant Buchanan, Paul S. Craft, Miao Yang, Albert Cheong, Jennifer Prescott, Li Jia, Gerhard A. Coetzee, and Wayne D. Tilley
Abstract: <h4>Background</h4>Two sublines of the human prostate cancer cell line, PC-3, which is widely used as a model of prostate cancer progression, have been reported: PC-3(AR-) that do not express androgen receptor (AR), and PC-3AR+ that have measurable AR RNA but little protein.<h4>Methods</h4>We assayed the geneotype, karyotype, AR expression, and physical characteristics of the two PC-3 sublines, and compared their ability to elicit a transactivation response from ectopic AR in the presence and absence of specific AR coregulators.<h4>Results</h4>PC-3(AR-) and PC-3AR+ cells are genotypically and karyotypically similar, but exhibit salient differences in their morphology, growth rate, and expression of AR RNA. Whereas endogenous AR expression in PC-3AR+ cells does not result in sufficient protein to confer androgen responsiveness in culture, ectopic AR consistently elicited a much greater transactivation response in PC-3AR+ than in PC-3(AR-) cells, without altered sensitivity to activation by native ligand or AR coregulators including GRIP1, BRCA1, and Zac1. Moreover, phenotypic differences of AR variants implicated in prostate cancer susceptibility and progression were only observed in PC-3AR+ cells. Higher levels of known AR coregulator proteins detected in PC-3AR+ compared with PC-3(AR-) cells likely contribute to these differences.<h4>Conclusions</h4>These studies provide new evidence that the androgen-signaling axis can be sensitized in prostate cancer cells, and have important implications for the analysis and interpretation of AR structure and function in in vitro cell systems.
Keywords: androgen ablation
androgen receptor
prostate cancer
Description: © 2004 Wiley-Liss,Inc. The definitive version may be found at
DOI: 10.1002/pros.20079
Published version:
Appears in Collections:Aurora harvest
Medicine publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.